Moderator: James R. Holmes, MD
Faculty: Fred Finney, MD; Scott Ellis, MD; Paul Hilliard, MD; A. Holly Johnson, MD; John Anderson, MD

The last several years have seen an incredible increase in the use and misuse of opioids in the United States. Orthopaedic surgeons have been a significant contributor to what is now called an opioid epidemic. This webinar will outline the history of the epidemic, review evidence-based guidelines for analgesia, dispel myths that contribute to the overprescription of opioids, provide alternatives, and offer safe and effective postoperative protocols for pain management.

At the conclusion of this webinar, you will be able to:

• Understand the complex interplay of factors that have contributed to the opioid epidemic
• Identify a broad range of analgesic measures; pharmacologic and procedural 
• Understand an evidence-based, multimodal, analgesic approach to maximize patient satisfaction and safety and minimize risk

AOFAS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AOFAS designates this Enduring Material for a maximum of up to 1.5 AMA PRA Category 1 Credits™

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation
The American Orthopaedic Foot & Ankle Society (AOFAS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.

Credit Designation Statement
The AOFAS designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirements of the American Board of Orthopaedic Surgery’s Maintenance of Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABOS credit.

CME Certificates
Participants are required to listen to the podcast, answer the evaluation and claim CME at the end of the webinar.

This webinar was reviewed and re-approved by the on-demand education committee for three years on 3/27/2024.

A need for this educational activity has been determined based on previous course evaluations and the AOFAS educational curriculum. The content of this course was based on current issues and topics provided by AOFAS membership and leadership. For more information on the AOFAS CME mission, visit aofas.org/education.

AOFAS requires all instructors, planners, and other individuals in a position to control or influence the content of an educational activity to disclose all relevant financial relationships or affiliations during the past 12 months with any commercial interest (any entity producing, marketing, re-selling, or distributing healthcare goods and services consumed by, or used on patients). All identified conflicts of interest must be resolved and the education content vetted by AOFAS for fair balance, scientific objectivity, and appropriateness. AOFAS also requires faculty to disclose when off-label/unapproved uses of a product are discussed in a CME activity. AOFAS attests that the persons responsible for the development of this educational activity did so independently and were not influenced by commercial supporters. All financial disclosures will be provided to meeting attendees in the final program materials.

The material presented in this continuing medical education activity has been made available by the American Orthopaedic Foot & Ankle Society (AOFAS) for educational purposes only. This material is not intended to represent the only, nor necessarily the best, methods or procedures appropriate for the medical situation discussed, but rather is intended to present an approach, view, statement, or opinion of the authors or presenters, which may be helpful or of interest to other practitioners. Methods, techniques, and procedures demonstrated and views and opinions expressed by speakers, presenters, and faculty are their own, and do not necessarily represent those of AOFAS, nor does presentation on the program represent or constitute endorsement or promotion by AOFAS. AOFAS expressly disclaims any warranties or guarantees, expressed or implied, and shall not be liable for damages of any kind in connection with the material, methods, information, techniques, opinions, or procedures expressed, presented, or demonstrated.

FDA Statement
Some drugs or medical devices demonstrated at this meeting have not been cleared by the FDA or have been cleared by the FDA for specific purposes only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or medical devices he or she wishes to use in clinical practice. AOFAS policy provides that “off label” uses of a drug or medical device may be described in its CME activities so long as the “off label” use of the drug or medical device is also specifically disclosed (i.e., it must be disclosed that the FDA has not cleared the drug or device for the described purpose). Any drug or medical device is being used “off label” if the described use is not set forth on the products approval label.

Faculty/Planner Disclosure Declaration
As an Accreditation Council for Continuing Medical Education (ACCME) provider, AOFAS has the obligation to ensure the delivery of education that is balanced and free of commercial bias. To achieve this, it is the policy of the AOFAS that all CME-related board members, committee members (“planners”), faculty, and appropriate staff disclose in writing to the learners’ all financial relationships that you have had in the past 24 months with ineligible companies. An “ineligible company” are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

In addition to faculty members, commentators from the floor are charged with verbally disclosing any interests immediately prior to speaking. All disclosures are provided in this final program distributed at the meeting to all program participants.

In accordance with AOFAS policy:
Faculty participation in this educational activity will be predicated upon timely submission and review of AOFAS disclosure. An individual who refuses to disclose all financial relationships will be disqualified from being a planning committee member, a teacher, or an author of CME, and cannot have control of, or responsibility for, the development, management, presentation, or evaluation of the CME activity. Non-compliance will result in a faculty member being stricken from the program.

An indication of the participant’s disclosure appears after his or her name as well as the ineligible company that provided the support. AOFAS does not view the existence of these disclosed interests or commitments as necessarily implying bias or decreasing the value of the author’s participation in this activity. In addition to ensuring that presentations be free of bias, faculty members are required to ensure that all material presented and discussed will be based on best- available evidence.

WEBINAR FACULTY DISCLOSURES

James R Holmes, MD
AAOS: Board or committee member
American Orthopaedic Foot and Ankle Society: Board or committee member

Fred (Bert) Finney, MD
(This individual reported nothing to disclose)

Scott Ellis, MD
American Orthopaedic Foot and Ankle Society: Board or committee member Foot and Anke Orthopaedics: Editorial or governing board
Paragon 28: Paid consultant
Wright Medical Technology, Inc.: Paid consultant

Anne (Holly) Johnson, MD
American Orthopaedic Foot and Ankle Society: Board or committee member 
AOFAMISS: Board or committee member
Novastep: IP royalties; Paid consultant Synthes: Paid consultant
Wright Medical Technology, Inc.: Paid consultant

Paul Hilliard, MD
(This individual reported nothing to disclose)

John G Anderson, MD
American Orthopaedic Foot and Ankle Society: Board or committee member Biomet: Paid consultant
Stryker: IP royalties; Paid consultant; Paid presenter or speaker 
Wright Medical Technology, Inc.: Research support

Education Committee Disclosures (Program Planners)

Michelle J Adams - Staff
(This individual reported nothing to disclose)

W Hodges Davis, MD
AAOS: Board or committee member
American Orthopaedic Foot and Ankle Society: Tulane Medical Alumni Association Board: Board or committee member
Amniox: Paid consultant; Research support
Arthrex, Inc: IP royalties; Paid consultant; Research support
DJ Orthopaedics: IP royalties; Other financial or material support; Paid consultant
Foot and Ankle International: Editorial or governing board
Wright Medical Technology, Inc.: IP royalties; Other financial or material support; Paid consultant; Paid presenter or speaker; Research support

Daniel C Farber, MD
AAOS: Board or committee member
American Orthopaedic Foot and Ankle Society: Board or committee member
Foot and Ankle Online: Editorial or governing board
JMEA: Stock or stock Options

Alena Frey - Staff
(This individual reported nothing to disclose)

Lauren Elizabeth Geaney, MD
Arthrex, Inc: Research support
Connecticut Orthopaedic Society: Board or committee member
Paragon 28: Paid consultant
Techniques in Orthopaedics: Editorial or governing board

Christopher E Gentchos, MD
American Orthopaedic Foot and Ankle Society: Board or committee member
New Hampshire Orthopaedic Society: Board or committee member

Steven L Haddad, MD
AAOS: Board or committee member  
American Orthopaedic Foot and Ankle Society: Board or committee member  
Foot and Ankle International: Editorial or governing board   
Tornier: Stock or stock Options  
Wright Medical Technology, Inc.: IP royalties; Paid consultant   
Zimmer: Paid consultant

Thomas M Hearty, MD
American Orthopaedic Foot and Ankle Society: Board or committee member Orthobullets: Editorial or governing board 

Anish Raj Kadakia, MD
AAOS: Board or committee member
Acumed, LLC: IP royalties
American Orthopaedic Foot and Ankle Society: Board or committee member Arthrex, Inc: Paid consultant; Paid presenter or speaker; Research support Biomedical Enterprises: IP royalties
DePuy, A Johnson & Johnson Company: IP royalties Elsevier: Publishing royalties, financial or material support LWW: Publishing royalties, financial or material support

James Robert Lachman, MD
Synthes: Paid presenter or speaker

Daniel Latt, MD, PhD
American Journal of Sports Medicine: Editorial or governing board
American Orthopaedic Foot and Ankle Society: Board or committee member Foot and Ankle International: Editorial or governing board
Foot and Ankle Orthopaedics: Editorial or governing board Footbeat: Unpaid consultant
Guided Therapy Systems: Research support Medshape: Paid consultant; Stock or stock Options Medshape, Inc.: Paid presenter or speaker
Orthopaedic Journal of Sports Medicine: Editorial or governing board Paragon 28: Paid presenter or speaker; Research support
Wright Medical Technology, Inc.: Paid presenter or speaker; Research support

Pamela Chiu-Wan Luk, MD
American Orthopaedic Foot and Ankle Society: Board or committee member

Garnett Andrew Murphy, MD
Allostem,: Research support
American Orthopaedic Foot and Ankle Society: Board or committee member Arthrex, Inc: Research support
Biomimetic: Research support
Ferring Pharmaceuticals: Research support
Foot and Ankle International: Editorial or governing board
Saunders/Mosby-Elsevier: Publishing royalties, financial or material support Smith & Nephew: Research support
Wright Medical Technology, Inc.: IP royalties; Paid consultant; Paid presenter or speaker; Research support

Julie Murkowski - Staff
(This individual reported nothing to disclose)

Irvin Oh, MD
(This individual reported nothing to disclose)

Vinod Kumar Panchbhavi, MD, FACS
AAOS: Board or committee member
American Orthopaedic Foot and Ankle Society: Board or committee member
Foot and Ankle InternationalTechniques in Foot & Ankle SurgeryOrthopedia.com: Editorial or governing board Stryker: Paid presenter or speaker
Wolters Kluwer Health - Lippincott Williams & Wilkins: Publishing royalties, financial or material support

Ruth Lourdes Thomas, MD
AAOS: Board or committee member
American Orthopaedic Foot and Ankle Society: Board or committee member Foot and Ankle International: Editorial or governing board
Johnson & Johnson: Stock or stock Options Pfeizer: Stock or stock Options
Ruth Jackson Orthopaedic Society: Board or committee member Stryker: Stock or stock Options
Teva: Stock or stock Options Zimmer: Stock or stock Options

David B Thordarson, MD
American Orthopaedic Foot and Ankle Society: Board or committee member Bio 2: Stock or stock Options
Foot and Ankle International: Editorial or governing board; Publishing royalties, financial or material support 
Paragon 28: Research support; Stock or stock Options
Stryker: Paid consultant; Paid presenter or speaker

João Filipe Vide, MD
American Orthopaedic Foot and Ankle Society: Board or committee member
European Federation of National Associations of Orthopedics and Traumatology: Board or committee member

Brian M Weatherford, MD
BESPA Global: Paid consultant
Orthobullets: Paid consultant Synthes: Paid presenter or speaker

Wang Xu, MD
(This individual reported nothing to disclose)

Jacob Rothschild Zide, MD
(This individual reported nothing to disclose)

All of the relevant financial relationships listed for these individuals have been mitigated.